Paper3000790
Variable bioavailability following repeated oral doses of etoposide.
Harvey VJ and 5 others. Eur J Cancer Clin Oncol, 1985. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Variable bioavailability following repeated oral doses of etoposide. Papers, record 3000790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000790
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Etoposide | Major topic |
| Podophyllotoxin | Major topic |
| Adult | |
| Biological Availability | |
| Carcinoma, Small Cell | |
| Drug Administration Schedule | |
| Humans | |
| Kinetics | |
| Lung Neoplasms | |
| Mesothelioma | |
| Time Factors |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37594527 | Novel Meta-iodobenzylguanidine and Etoposide Complex: Physicochemical Characterization and Mathematical Modeling of Anticancer Activity. | AAPS PharmSciTech | 2023 | https://conductscience.org/library/papers/37594527 | PubMed |
| 15956976 | Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15956976 | PubMed |
| 15139794 | Pharmacokinetic optimisation of treatment with oral etoposide. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15139794 | PubMed |
| 10958591 | The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery. | Invest New Drugs | 2000 | https://conductscience.org/library/papers/10958591 | PubMed |
| 9400945 | Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9400945 | PubMed |
| 9184183 | Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9184183 | PubMed |
| 8797893 | Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8797893 | PubMed |
| 8609070 | Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8609070 | PubMed |
| 8286205 | Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8286205 | PubMed |
| 8258198 | A limited sampling model for the pharmacokinetics of etoposide given orally. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8258198 | PubMed |
| 7497587 | Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497587 | PubMed |
| 7497581 | Pharmacological attempts to improve the bioavailability of oral etoposide. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497581 | PubMed |
| 7497580 | Stability of the i.v. and oral formulations of etoposide in solution. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497580 | PubMed |
| 3621455 | Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3621455 | PubMed |
| 3555940 | Pharmacokinetics of anticancer drugs in children. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3555940 | PubMed |
| 3315283 | Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3315283 | PubMed |
| 3311530 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311530 | PubMed |
| 3297462 | The clinical pharmacology of etoposide and teniposide. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3297462 | PubMed |
| 3004772 | The effect of dose on the bioavailability of oral etoposide. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3004772 | PubMed |
| 2758563 | The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2758563 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3000790
GET https://conductscience.org/api/papers/v1/3000790/cited_by?page=2